Process for manufacturing flowable powder drug compositions
Powder drug compositions exhibiting improved flow properties are manufactured by spraying a suspension of surface-modified nanoparticles having an average particle size diameter of less than 100 nm in a dryable liquid carrier onto particles of a powder ingredient of a drug composition. The liquid carrier is rapidly dried so as to leave the nanoparticles on the powder. Other ingredients of the powder drug composition can also be added.
1. A process for manufacturing a powder drug composition, comprising:
preparing a suspension of surface-modified nanoparticles having an average particle size diameter of less than 100 nm in a dryable liquid carrier;
spraying the dryable liquid carrier containing the surface-modified nanoparticles onto particles of a powder ingredient of a drug composition;
evaporating off the dryable liquid carrier so as to leave the surface-modified nanoparticles on the powder ingredient without the dryable liquid carrier; and
optionally adding other ingredients of the powder drug composition.
2. The process of claim 1 , wherein the surface-modified nanoparticles have a hydrophilic surface modification.
3. The process of claim 1 , wherein the surface-modified nanoparticles have a hydrophobic surface modification.
4. The process of claim 1 , wherein the surface-modified nanoparticles comprise nanoparticles having a surface modification selected from one of at least two different surface modifications, wherein at least one surface modification is hydrophilic and at least one surface modification is hydrophobic.
5. The process claim 1 , wherein the nanoparticles have a core material selected from the group consisting of silicas, calcium phosphates, iron oxides, zinc oxides, zirconia and alumina compounds.
6. The process of claim 1 , wherein the average diameter of the surface-modified nanoparticles is less than 20 nm.
7. The process of claim 1 , wherein the dryable liquid carrier is selected from the group consisting of water, isopropyl alcohol, ethanol, dimethyl ether, heptane, toluene, liquefied carbon dioxide, liquefied hydrocarbon, liquefied hydrofluorocarbon, and mixtures thereof.
8. The process of claim 7 , wherein the dryable liquid carrier is isopropyl alcohol.
9. The process of claim 7 , wherein the dryable liquid carrier is heptane.
10. The process of claim 1 , wherein the particles of the powder drug composition have a median particle size diameter less than 200 micrometers.
11. The process of claim 1 , wherein the powder drug composition is a powdered medicament formulation.
12. The process of claim 1 , wherein the powder ingredient comprises lactose.
13. The process of claim 11 , wherein the powdered medicament formulation is a dry powder inhaler formulation.
14. The process of claim 1 , wherein the particles of the powder ingredient are stirred as the dryable liquid carrier containing surface-modified nanoparticles is sprayed onto the particles of the powder ingredient.
15. The process of claim 1 , wherein the liquid carrier is removed by vacuum filtration, spray drying, rotary evaporation, bulk evaporation or freeze drying.
16. The process of claim 1 , wherein the particles of the powder ingredient form a bed of particles on a filtration media through which a suction is applied to the bed of particles.
17. The process of claim 1 , wherein the particles of the powder ingredient are airborne when the dryable liquid carrier containing nanoparticles is sprayed onto the surface of the powder ingredient.
18. The process of claim 17 , wherein the particles of the powder ingredient are contained in one airflow that impinges upon a second airflow containing droplets of the dryable liquid carrier containing nanoparticles.